Company Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products.
This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support.
This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors.
West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
| Country | United States |
| Founded | 1923 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 10,600 |
| CEO | Eric Green |
Contact Details
Address: 530 Herman O. West Drive Exton, Pennsylvania 19341-1147 United States | |
| Phone | 610 594 2900 |
| Website | westpharma.com |
Stock Details
| Ticker Symbol | WST |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000105770 |
| CUSIP Number | 955306105 |
| ISIN Number | US9553061055 |
| Employer ID | 23-1210010 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Eric M. Green | Non-Independent Chair of the Board, President and Chief Executive Officer |
| Bernard J. Birkett | Senior Vice President and Chief Financial Officer |
| Kimberly Banks MacKay | Senior Vice President, General Counsel and Company Secretary |
| Kathy DePadua | Senior Vice President and Chief Quality and Regulatory Officer |
| Aileen Ruff-Patry | President of Contract Manufacturing |
| Don O'Callaghan | President of Drug Delivery Devices |
| Andy Polywacz | President of Integrated Systems |
| Aileen Kinsella | Head of Proprietary Product Sales |
| Charles Witherspoon CPA | Vice President and Treasurer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 21, 2025 | ARS | Filing |
| Mar 21, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 21, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 11, 2025 | PRE 14A | Other preliminary proxy statements |
| Mar 11, 2025 | 8-K | Current Report |
| Feb 18, 2025 | 10-K | Annual Report |
| Feb 13, 2025 | 8-K | Current Report |
| Dec 13, 2024 | 8-K | Current Report |
| Dec 11, 2024 | 8-K | Current Report |
| Oct 24, 2024 | 10-Q | Quarterly Report |